gatifloxacin has been researched along with Diabetic Ketoacidosis in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Diabetic Ketoacidosis: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin has been reported to cause dysglycaemia, especially in the elderly and in diabetics." | 1.35 | Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient. ( Agarwal, SK; Gupta, A; Khaira, A; Tandon, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaira, A | 1 |
| Gupta, A | 1 |
| Tandon, N | 1 |
| Agarwal, SK | 1 |
1 other study available for gatifloxacin and Diabetic Ketoacidosis
| Article | Year |
|---|---|
Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.
Topics: Anti-Infective Agents; Diabetic Ketoacidosis; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; | 2009 |